Everolimus-eluting versus paclitaxel-eluting stents.
Kounis
Nicholas G
NG
Goudevenos
John A
JA
D054855:Drug-Eluting Stents; D004867:Equipment Design; D000068338:Everolimus; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D007166:Immunosuppressive Agents; D009532:Nickel / Q000009:adverse effects; D017239:Paclitaxel; D020123:Sirolimus / Q000031:analogs & derivatives*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D007166:Immunosuppressive Agents; D009532:Nickel; D000068338:Everolimus; D017239:Paclitaxel; D020123:Sirolimus